ABCL vs CLOV
Abcellera Biologics Inc (ABCL) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ABCL revenue for 2024-12-31 was $28.8M. Net income was -$162.9M. Revenue was down 24.2% from 2023-12-31 to 2024-12-31. ABCL currently screens at market cap $1.12B.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ABCL currently screens at market cap $1.12B. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ABCL and CLOV stock pages for the full models.
Not investment advice.